Originally posted to Business Wire on March 18, 2026 GAITHERSBURG, Md.–(BUSINESS WIRE)–Mirecule, Inc., a leader in Antibody RNA Conjugate (ARC) therapeutics targeting rare neuromuscular diseases, today announced an expansion of … Continue reading Mirecule Expands Strategic FSHD Collaboration with Sanofi